SBIR-STTR Award

Toxicological screening in a single animal format
Award last edited on: 4/12/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NIEHS
Total Award Amount
$259,613
Award Phase
1
Solicitation Topic Code
142
Principal Investigator
Guochun He

Company Information

Theramix LLC

1045 California Street Suite A
Mountain View, CA 94041
   (650) 564-4941
   N/A
   www.theramixmed.com
Location: Single
Congr. District: 18
County: Santa Clara

Phase I

Contract Number: 1R43ES034324-01
Start Date: 9/23/2022    Completed: 8/31/2023
Phase I year
2022
Phase I Amount
$259,613
Toxicity testing with animals has limitations with regards to cost, time, reliability, and animalwelfare. We propose to develop a novel toxicological screening approach in a single animal formatfor quickly assessing the safety of chemicals with reduction of animal use and improved animalwelfare. We will develop a new testing procedure with which we could perform tests in only oneanimal to obtain information on the effective doses, impacted tissues, and organs, andtoxicodynamics of toxicants, which usually need experimenting on hundreds of animals, monthsto years efforts, and enormous biochemical and pathological analyses in the traditionaltoxicological study. The breakthrough technique is a reporter system for real-time mapping cellulardamage caused by chemical substances in the whole body. It can detect the toxic effects ofsubstances as early as cellular damage occurs in the body. Whereas in traditional animal testing,adverse effects only become detectable/measurable in animals exhibiting significant degrees ofadverse health effects after receiving high doses of test chemicals. Instead of taking the animalbody as a "black box" in the traditional testing, our new technique enables real-time monitoringresponses to a chemical by making the animal body transparent for directly observing adverseeffects at the cellular level.

Public Health Relevance Statement:
Public Health Relevance The success of the project would bring us a new toxicological screening approach that allows fast, cost-effective toxicity testing in a single animal that helps to significantly reduce the number of animals being used and improve animal welfare. More importantly, our definition of toxicity by damage at the cellular level may be more meaningful for safety prediction in humans than LD50 or other traditional toxicological parameters obtained from illnesses exaggerated in animals with high-dose.

Project Terms:

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----